Holen Sie sich die Stockscreener-App
0.4127
3.00%
-0.0113
Schlusskurs vom Vortag:
$0.424
Offen:
$0.4274
24-Stunden-Volumen:
320.79K
Relative Volume:
0.40
Marktkapitalisierung:
$18.30M
Einnahmen:
$106.79M
Nettoeinkommen (Verlust:
$-8.73M
KGV:
-2.0635
EPS:
-0.2
Netto-Cashflow:
$10.81M
1W Leistung:
-6.92%
1M Leistung:
-15.18%
6M Leistung:
+5.46%
1J Leistung:
-83.14%
1-Tages-Spanne:
$0.4103
$0.4274
1-Wochen-Bereich:
$0.41
$0.445
52-Wochen-Spanne:
$0.2813
$2.82
Harvard Bioscience Inc Stock (HBIO) Company Profile
Firmenname
Harvard Bioscience Inc
Sektor
Telefon
(508) 893-8999
Adresse
84 OCTOBER HILL RD, HOLLISTON, MA
Vergleichen Sie HBIO mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
HBIO
Harvard Bioscience Inc
|
0.411 | 18.73M | 106.79M | -8.73M | 10.81M | -0.20 |
|
ISRG
Intuitive Surgical Inc
|
435.39 | 156.44B | 9.15B | 2.63B | 1.99B | 7.1661 |
|
BDX
Becton Dickinson Co
|
183.37 | 53.99B | 21.39B | 1.61B | 2.55B | 5.5609 |
|
RMD
Resmed Inc
|
269.99 | 39.41B | 5.15B | 1.40B | 1.65B | 9.5082 |
|
ALC
Alcon Inc
|
75.07 | 36.63B | 10.03B | 1.07B | 1.39B | 2.1549 |
|
WST
West Pharmaceutical Services Inc
|
265.63 | 18.78B | 2.96B | 487.70M | 344.00M | 6.6758 |
Harvard Bioscience Inc Stock (HBIO) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-04-09 | Herabstufung | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2023-03-10 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
| 2021-01-07 | Hochstufung | The Benchmark Company | Speculative Buy → Buy |
| 2020-12-09 | Eingeleitet | Northland Capital | Outperform |
| 2020-11-10 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2019-07-08 | Herabstufung | Janney | Buy → Neutral |
| 2018-01-24 | Bestätigt | Janney | Buy |
| 2018-01-23 | Bestätigt | The Benchmark Company | Buy |
| 2016-11-17 | Eingeleitet | Singular Research | Buy |
| 2015-07-28 | Eingeleitet | The Benchmark Company | Buy |
Alle ansehen
Harvard Bioscience Inc Aktie (HBIO) Neueste Nachrichten
Using economic indicators to assess Harvard Bioscience Inc. potential2025 Technical Patterns & Smart Investment Allocation Insights - newser.com
Will Harvard Bioscience Inc. stock outperform Nasdaq index2025 Earnings Surprises & High Accuracy Investment Entry Signals - newser.com
Momentum divergence signals in Harvard Bioscience Inc. chart2025 Top Decliners & Weekly Return Optimization Plans - newser.com
Is Harvard Bioscience Inc. (HBI) stock supported by free cash flowWeekly Market Outlook & Low Volatility Stock Suggestions - newser.com
Applying Wyckoff theory to Harvard Bioscience Inc. stockWeekly Volume Report & Verified Stock Trade Ideas - newser.com
Harvard Bioscience Inc. stock chart pattern explainedPortfolio Risk Report & Free Expert Verified Stock Movement Alerts - newser.com
Top chart patterns to watch in Harvard Bioscience Inc.2025 Institutional Moves & Consistent Growth Stock Picks - newser.com
Is Harvard Bioscience Inc. (HBI) stock worth holding before Fed meetingSwing Trade & Daily Price Action Insights - newser.com
Forecasting Harvard Bioscience Inc. price range with options data2025 Institutional Moves & Weekly Chart Analysis and Guides - newser.com
Will Harvard Bioscience Inc. stock reach Wall Street targetsTrade Signal Summary & Safe Entry Momentum Stock Tips - newser.com
What analysts say about Harvard Bioscience Inc stockUtilities Sector Analysis & Double Or Triple Returns - earlytimes.in
What drives Harvard Bioscience Inc stock priceAnalyst Downgrades & Stocks With 200% Upside Potential - earlytimes.in
Is Harvard Bioscience Inc. (HBI) stock at risk of policy regulationJuly 2025 Analyst Calls & Free Long-Term Investment Growth Plans - newser.com
What’s the recovery path for long term holders of Harvard Bioscience Inc.2025 Short Interest & Fast Gaining Stock Reports - newser.com
How to integrate Harvard Bioscience Inc. into portfolio analysis toolsEarnings Summary Report & Accurate Entry/Exit Alerts - newser.com
Harvard Bioscience appoints interim CFO amid market challenges By Investing.com - Investing.com Nigeria
Harvard Bioscience gets another 180 days to try to stay on the Nasdaq - Worcester Business Journal
Harvard Bioscience granted 180 days for complianceSEC filing - MarketScreener
Harvard Bioscience receives extension to regain Nasdaq bid price compliance - Investing.com
Harvard Bioscience Granted Nasdaq Compliance Extension - TipRanks
Applying Elliott Wave Theory to Harvard Bioscience Inc.2025 Technical Overview & Smart Investment Allocation Tips - newser.com
Is it too late to sell Harvard Bioscience Inc.Portfolio Growth Summary & Capital Efficiency Focused Ideas - newser.com
What machine learning models say about Harvard Bioscience Inc.Quarterly Growth Report & Capital Efficient Trade Techniques - newser.com
Why Harvard Bioscience Inc. (HBI) stock is a strong buy callJuly 2025 Technicals & Verified Swing Trading Watchlists - newser.com
What high frequency data says about Harvard Bioscience Inc.2025 Valuation Update & Long-Term Growth Stock Strategies - newser.com
Finanzdaten der Harvard Bioscience Inc-Aktie (HBIO)
Umsatz
Nettogewinn
Free Cashflow
ENV
5.48%
0.49%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):